Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human luteinizing hormone

lutropin alfa
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Recombinant human luteinizing hormone, covering 2012-06-20 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) [Phase 3]

See pricing